Carlyle Group Inc. and PAI Partners agreed to buy women’s health business Theramex from private equity firm CVC Capital Partners.
The consortium announced the acquisition of London-based Theramex in a statement Monday, without disclosing financial terms. Bloomberg News reported earlier that Carlyle and Paris-based PAI were nearing a deal for about $1.4 billion after outbidding other suitors.
PAI plans to help Theramex expand further through “organic and inorganic growth initiatives,” it said in the statement. Washington-based Carlyle said it will help support the drug firm’s “international growth ambitions.” PAI has about 22.4 billion euros ($24.6 billion) under management, while Carlyle oversees about $301 billion of assets spanning private equity, credit and other investment solutions.
Read more: BNN Bloomberg
